-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Raphael Pharmaceutical Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2020 to Q3 2024.
- Raphael Pharmaceutical Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$326K, a 55% increase year-over-year.
- Raphael Pharmaceutical Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$1M, a 60.1% increase year-over-year.
- Raphael Pharmaceutical Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$1.28M, a 61.8% increase from 2022.
- Raphael Pharmaceutical Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$3.36M, a 107% decline from 2021.
- Raphael Pharmaceutical Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$1.63M, a 126% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)